Plain-English summary
Court says retailers who would have sold denied tobacco products can challenge FDA denials
The Court held that retailers who would have sold a new tobacco product but for the FDA’s denial have the right to seek judicial review of the agency’s decision under 21 U.S.C. §387l(a)(1). The judgment from the Fifth Circuit is affirmed and the case remanded.
Why this matters
This decision clarifies who may challenge FDA denials of new tobacco products. By allowing downstream sellers to obtain judicial review, the ruling gives retailers and other market participants a direct path to contest agency decisions that affect their ability to sell particular products. That can affect enforcement, litigation strategy, and how quickly denied products are removed from or kept off the market.
Who may feel it
- Retailers and distributors of tobacco and vaping products
- Tobacco product manufacturers and applicants
- Consumers of electronic nicotine delivery systems and other tobacco products
- FDA and other regulatory agencies that review product authorizations
- Trade associations and industry lawyers involved in tobacco regulation